Corinna Warburton

1.4k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Corinna Warburton is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Corinna Warburton has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Corinna Warburton's work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Corinna Warburton is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Corinna Warburton collaborates with scholars based in Canada, France and Iran. Corinna Warburton's co-authors include Lyn Powell-Braxton, Mary Dowd, Dyana K. Dalton, Timothy A. Stewart, Philip G. Hollingshead, Nancy A. Gillett, Sharon Pitts-Meek, Marcel B. Bally, Wieslawa H. Dragowska and Karen A. Gelmon and has published in prestigious journals such as Genes & Development, PLoS ONE and Cancer Research.

In The Last Decade

Corinna Warburton

16 papers receiving 1.1k citations

Hit Papers

IGF-I is required for nor... 1993 2026 2004 2015 1993 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IGF-I is required for normal embryonic growth in mice.
    1993 635 citations Lyn Powell-Braxton, Philip G. Hollingshead et al. Genes & Development profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corinna Warburton Canada 13 649 384 179 155 129 16 1.1k
Saulius Žuklys Switzerland 17 802 1.2× 329 0.9× 290 1.6× 335 2.2× 69 0.5× 28 2.1k
Nina Horelli‐Kuitunen Finland 18 720 1.1× 561 1.5× 635 3.5× 126 0.8× 90 0.7× 37 1.9k
J K Anderson United States 13 949 1.5× 350 0.9× 164 0.9× 212 1.4× 38 0.3× 21 1.4k
Susana García‐Silva Spain 17 634 1.0× 241 0.6× 156 0.9× 283 1.8× 82 0.6× 24 1.2k
Geeta Upadhyay United States 16 596 0.9× 143 0.4× 104 0.6× 266 1.7× 72 0.6× 31 1.2k
Paolo Simi Italy 22 633 1.0× 131 0.3× 571 3.2× 243 1.6× 120 0.9× 82 1.4k
Philip G. Hollingshead United States 13 964 1.5× 481 1.3× 426 2.4× 183 1.2× 29 0.2× 16 1.9k
Agneta Levinovitz Sweden 11 465 0.7× 175 0.5× 95 0.5× 121 0.8× 59 0.5× 12 1.0k
Frances Benham United Kingdom 17 648 1.0× 171 0.4× 370 2.1× 122 0.8× 36 0.3× 35 1.1k
Lamis Yehia United States 17 543 0.8× 87 0.2× 148 0.8× 164 1.1× 77 0.6× 48 883

Countries citing papers authored by Corinna Warburton

Since Specialization
Citations

This map shows the geographic impact of Corinna Warburton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinna Warburton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinna Warburton more than expected).

Fields of papers citing papers by Corinna Warburton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corinna Warburton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinna Warburton. The network helps show where Corinna Warburton may publish in the future.

Co-authorship network of co-authors of Corinna Warburton

This figure shows the co-authorship network connecting the top 25 collaborators of Corinna Warburton. A scholar is included among the top collaborators of Corinna Warburton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinna Warburton. Corinna Warburton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Leung, Ada W.Y., Chansey J. Veinotte, Min Hee Oh, et al.. (2017). In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target. Clinical Cancer Research. 23(21). 6555–6566. 9 indexed citations
2.
Leung, Ada W.Y., Chansey J. Veinotte, Ian Backstrom, et al.. (2016). Abstract 3792: PAPSS1 (3’-phosphoadenosine 5’-phosphosulfate synthase 1) inhibition sensitizes non-small cell lung cancer to cisplatin treatment in vivo. Cancer Research. 76(14_Supplement). 3792–3792. 1 indexed citations
3.
Leung, Ada W.Y., Wieslawa H. Dragowska, Brian Kwok, et al.. (2015). 3′-Phosphoadenosine 5′-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents. Oncotarget. 6(19). 17161–17177. 19 indexed citations
4.
Verreault, Maïté, et al.. (2013). Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model. PLoS ONE. 8(3). e59597–e59597. 25 indexed citations
5.
Dragowska, Wieslawa H., Sherry A. Weppler, Anita I. Kapanen, et al.. (2013). Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer. PLoS ONE. 8(10). e76503–e76503. 91 indexed citations
6.
7.
8.
Chiu, Gigi N.C., Lincoln Edwards, Anita I. Kapanen, et al.. (2007). Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs. Molecular Cancer Therapeutics. 6(3). 844–855. 51 indexed citations
9.
Dragowska, Wieslawa H., Maïté Verreault, Donald T. Yapp, et al.. (2007). Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin. Breast Cancer Research and Treatment. 106(3). 319–331. 15 indexed citations
10.
Thornton, Sheila J., Corinna Warburton, Kishor M. Wasan, & Piotr Kozłowski. (2007). Treatment with a Cholesterol Absorption Inhibitor (FM-VP4) Reduces Body Mass and Adipose Accumulation in Developing and Pre-Obese Mice. Drug Development and Industrial Pharmacy. 33(10). 1058–1069. 11 indexed citations
11.
Warburton, Corinna, et al.. (2007). Leishmania majorAbrogates Gamma Interferon-Induced Gene Expression in Human Macrophages from a Global Perspective. Infection and Immunity. 75(7). 3506–3515. 40 indexed citations
12.
Dragowska, Wieslawa H., Corinna Warburton, Donald T. Yapp, et al.. (2004). HER-2/neuOverexpression Increases the Viable Hypoxic Cell Population within Solid Tumors without Causing Changes in Tumor Vascularization. Molecular Cancer Research. 2(11). 606–619. 23 indexed citations
13.
14.
15.
Warburton, Corinna & Lyn Powell-Braxton. (1995). Mouse models of IGF-I deficiency generated by gene targeting.. PubMed. 5(1). 35–41. 13 indexed citations
16.
Powell-Braxton, Lyn, Philip G. Hollingshead, Corinna Warburton, et al.. (1993). IGF-I is required for normal embryonic growth in mice.. Genes & Development. 7(12b). 2609–2617. 635 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saulius Žuklys Breakdown of academic impact, for papers by Nina Horelli‐Kuitunen Breakdown of academic impact, for papers by J K Anderson Breakdown of academic impact, for papers by Susana García‐Silva Breakdown of academic impact, for papers by Geeta Upadhyay Breakdown of academic impact, for papers by Paolo Simi Breakdown of academic impact, for papers by Philip G. Hollingshead Breakdown of academic impact, for papers by Agneta Levinovitz Breakdown of academic impact, for papers by Frances Benham Breakdown of academic impact, for papers by Lamis Yehia
Rankless by CCL
2026